PitchSend

Investor Presentaiton

9MFY23 Performance Snapshot 3. & گاه 9MFY23 Key Highlights METROPOLIS The Pathology Specialist Total Revenue Rs. 866 Crores -6% YoY Revenue Excl. Covid PCR & Covid Allied tests Rs. 828 Crores 21% YOY Covid PCR & Allied Tests Revenue Rs. 37 Crores -84% YoY Volume (Excl. Covid PCR & Allied Tests) 18.4 Mn 21% YoY EBITDA Margin (Before CSR & ESOP) 26.8% Reported EBITDA Margin 25.8% Q3FY22 includes Hitech Diagnostics w.e.f 22nd Oct 2021 The board has declared interim dividend of Rs. 8 per equity share of Face value of Rs. 2 each to equity shareholder of the company 5

View entire presentation